$AMPE Ampio execs subpoenaed over alleged insider trading Nov. 7, 2019 4:57 PM ET|About: Ampio Pharmaceuticals,... (AMPE)|By: Douglas W. House, SA News Editor Ampio Pharmaceuticals (NYSEMKT:AMPE) discloses (10-Q, page 23) that one of its directors received a subpoena from the SEC requesting documents and information related to its ongoing investigation into potential insider trading. Certain executives and directors received the first subpoena (10-Q, page 22) in April related to the trading of securities near two corporate announcements that resulted in material declines in the stock price. The company believes all asserted claims are without merit and it intends to "vigorously" defend itself.
  • 1
  • 7